Acknowledgements
The authors would like to acknowledge Bridget Newsom for facilitating our constant communications with Novartis and her dedicated efforts in helping obtain tisagenlecleucel on compassionate use protocol for our patient. We would also like to acknowledge all the members of the Novartis team who supported our medical team through the pre- and post-collection challenges.